Vasodilators and Antihypertensive Agents
This area covers the major drug classes used to lower arterial blood pressure and to relax vascular smooth muscle. It groups direct vasodilators, inhibitors of the renin-angiotensin system (ACE inhibitors and angiotensin II receptor antagonists), calcium channel blockers, and diuretics, organising them by the physiological lever each class pulls within the determinants of blood pressure.
Definition
Antihypertensive and vasodilator agents are drugs that reduce arterial blood pressure or vascular tone by acting on one or more determinants of blood pressure: cardiac output, blood volume, peripheral vascular resistance, and the neurohormonal systems that regulate them.
Scope
The entry orients the reader to how these classes are organised pharmacologically and why blood-pressure reduction is a central therapeutic target, while linking out to the individual classes for mechanism, evidence, and class-specific detail. It is a reference overview of pharmacology, not a prescribing resource.
Sub-topics
Core questions
- Which determinant of blood pressure does each drug class principally act on?
- How do the renin-angiotensin system, vascular smooth-muscle calcium handling, and sodium-volume balance translate into therapeutic targets?
- What does outcome trial evidence show about lowering blood pressure across drug classes?
Key concepts
- Blood pressure as cardiac output times peripheral resistance
- Renin-angiotensin-aldosterone system
- Vascular smooth-muscle tone and calcium handling
- Sodium-volume balance and natriuresis
- Drug class as organising principle for antihypertensives
- Outcome-driven evidence for blood-pressure lowering
Mechanisms
Arterial blood pressure is the product of cardiac output and total peripheral resistance, each modulated by blood volume and by neurohormonal signalling. The drug classes in this area map onto these levers: direct vasodilators and calcium channel blockers reduce peripheral resistance by relaxing arterial smooth muscle; renin-angiotensin system inhibitors (ACE inhibitors and angiotensin II receptor antagonists) blunt angiotensin II-driven vasoconstriction and aldosterone-mediated sodium retention; and diuretics lower blood volume through renal sodium and water excretion. Because these mechanisms are partly complementary, combinations are common, and large trials have compared classes head to head for cardiovascular outcomes.
Clinical relevance
Blood-pressure lowering is one of the most studied interventions in cardiovascular medicine, and the relationship between usual blood pressure and vascular mortality is strong and graded across a wide range. This area describes how the major classes are defined and how evidence is generated for them; it is educational reference material and does not provide dosing or individualised treatment guidance.
Epidemiology
Elevated blood pressure is among the leading modifiable contributors to cardiovascular disease and stroke worldwide. Pooled cohort data indicate a continuous association between usual blood pressure and vascular death down to relatively low pressures, and randomised trials such as ALLHAT and SPRINT have informed how and how far blood pressure is lowered.
History
Effective oral antihypertensive therapy emerged over the second half of the twentieth century, beginning with ganglionic blockers and early diuretics and expanding through the development of beta-blockers, calcium channel blockers, ACE inhibitors, and angiotensin receptor blockers. Successive landmark trials and guideline updates, from JNC reports to the ESC/ESH and ACC/AHA statements, progressively defined class choice and treatment thresholds.
Debates
- How low should blood pressure be lowered, and does drug class matter for outcomes?
- Trials such as ALLHAT suggested broadly similar outcomes across several first-line classes when blood pressure is controlled, while SPRINT supported more intensive targets in selected populations; guidelines continue to weigh target intensity against class choice and tolerability.
Related topics
Seminal works
- lewington-2002
- allhat-2002
- whelton-2018
- williams-2018
Frequently asked questions
- What organises the drug classes in this area?
- Each class is grouped by the determinant of blood pressure it principally targets: peripheral resistance (vasodilators, calcium channel blockers), the renin-angiotensin system (ACE inhibitors, angiotensin receptor blockers), or blood volume (diuretics).
- Why is lowering blood pressure such a central therapeutic goal?
- Large pooled cohort data show a strong, graded association between usual blood pressure and vascular mortality, and randomised trials show that reducing blood pressure reduces cardiovascular events.